
Overview
Scott Schuetze is an Oncologist practicing medicine in Ann Arbor, Michigan.
Dr. Schuetze is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma.
He is actively involved in clinical research, co-authoring 97 peer reviewed articles and participating in 12 clinical trials. Dr. Schuetze is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Center Dr, Floor B1 Reception E, Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Schuetze has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
11 Clinical Trials
Rogel Cancer Center
Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.
Rogel Cancer Center
Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology. Dr. Vaishampayan is currently accepting new patients.
Rogel Cancer Center
The T-cell lymphomas are a heterogeneous and poorly understood group of non-Hodgkin’s lymphomas. The most common T-cell lymphoma in the United States includes a heterogeneous mix of lymphomas that lack distinguishing characteristics and, until recently, remained clinically and molecularly “unspecified”. Improved understanding of T-cell lymphoma pathogenesis and the development of novel therapeutic strategies will be needed to address this challenge and improve outcomes for patients afflicted with these aggressive lymphomas. My group made the landmark discovery that the most common T-cell lymphoma in North America is comprised of two molecularly and clinically distinct subsets. This finding has significant implications for the classification and treatment of these lymphomas. We have also demonstrated that malignant T cells remain dependent upon antigen-presenting cells within the tumor microenvironment and are developing novel therapeutic strategies targeting these cells. Many fundamental questions, including the “cell of origin”, the role of antigen-, costimulatory-, and cytokine-receptor signaling, and the contribution of myeloid-derived antigen-presenting cells in disease pathogenesis remain obscure. My laboratory uses complementary mouse models and primary T-cell lymphoma specimens (in ex vivo and patient-derived xenograft studies) to address these fundamental and clinically relevant questions. We are poised to clinically translate our laboratory-based findings into novel therapeutic strategies that we hope will improve outcomes for patients afflicted with these aggressive lymphomas. I enjoy working with a multidisciplinary team of enthusiastic collaborators who share this common goal. Dr. Wilcox is highly rated in 24 conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Wilcox is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Wilcox is currently accepting new patients.
Frequently Asked Questions about Dr. Scott M. Schuetze
How do I make an appointment with Dr. Scott M. Schuetze?
You can book an appointment with Dr. Scott M. Schuetze by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Scott M. Schuetze a top-rated expert for Liposarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Scott M. Schuetze is classified as an Elite expert for Liposarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Scott M. Schuetze specialize in?
While Dr. Scott M. Schuetze is a Oncology, they have specific expertise in Liposarcoma, Adult Soft Tissue Sarcoma, and Angiosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Scott M. Schuetze participate in research or clinical trials?
Yes. Dr. Scott M. Schuetze has published 97 articles and abstracts on conditions like Liposarcoma. You can view a list of Dr. Scott M. Schuetze's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Scott M. Schuetze accept my insurance?
Dr. Scott M. Schuetze accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Adult Soft Tissue SarcomaDr. Schuetze isElite. Learn about Adult Soft Tissue Sarcoma.
- AngiosarcomaDr. Schuetze isElite. Learn about Angiosarcoma.
- LiposarcomaDr. Schuetze isElite. Learn about Liposarcoma.
- Myxoid LiposarcomaDr. Schuetze isElite. Learn about Myxoid Liposarcoma.
- Synovial SarcomaDr. Schuetze isElite. Learn about Synovial Sarcoma.
- Undifferentiated Pleomorphic Sarcoma
- Distinguished
- Alveolar Soft Part SarcomaDr. Schuetze isDistinguished. Learn about Alveolar Soft Part Sarcoma.
- Angiosarcoma of the LiverDr. Schuetze isDistinguished. Learn about Angiosarcoma of the Liver.
- Bone TumorDr. Schuetze isDistinguished. Learn about Bone Tumor.
- ChondrosarcomaDr. Schuetze isDistinguished. Learn about Chondrosarcoma.
- Desmoid TumorDr. Schuetze isDistinguished. Learn about Desmoid Tumor.
- Desmoplastic Small Round Cell TumorDr. Schuetze isDistinguished. Learn about Desmoplastic Small Round Cell Tumor.
- Epithelioid SarcomaDr. Schuetze isDistinguished. Learn about Epithelioid Sarcoma.
- Ewing SarcomaDr. Schuetze isDistinguished. Learn about Ewing Sarcoma.
- FibrosarcomaDr. Schuetze isDistinguished. Learn about Fibrosarcoma.
- GanglioneuroblastomaDr. Schuetze isDistinguished. Learn about Ganglioneuroblastoma.
- GanglioneuromaDr. Schuetze isDistinguished. Learn about Ganglioneuroma.
- Gastrointestinal Stromal TumorDr. Schuetze isDistinguished. Learn about Gastrointestinal Stromal Tumor.
- Malignant Peripheral Nerve Sheath TumorDr. Schuetze isDistinguished. Learn about Malignant Peripheral Nerve Sheath Tumor.
- MesenchymomaDr. Schuetze isDistinguished. Learn about Mesenchymoma.
- OsteosarcomaDr. Schuetze isDistinguished. Learn about Osteosarcoma.
- Retroperitoneal LiposarcomaDr. Schuetze isDistinguished. Learn about Retroperitoneal Liposarcoma.
- Rhabdoid TumorDr. Schuetze isDistinguished. Learn about Rhabdoid Tumor.
- Rhabdoid Tumor Predisposition SyndromeDr. Schuetze isDistinguished. Learn about Rhabdoid Tumor Predisposition Syndrome.
- RhabdomyosarcomaDr. Schuetze isDistinguished. Learn about Rhabdomyosarcoma.
- Rhabdomyosarcoma EmbryonalDr. Schuetze isDistinguished. Learn about Rhabdomyosarcoma Embryonal.
- Advanced
- Angiosarcoma of the ScalpDr. Schuetze isAdvanced. Learn about Angiosarcoma of the Scalp.
- ChordomaDr. Schuetze isAdvanced. Learn about Chordoma.
- Dendritic Cell TumorDr. Schuetze isAdvanced. Learn about Dendritic Cell Tumor.
- Eccrine PorocarcinomaDr. Schuetze isAdvanced. Learn about Eccrine Porocarcinoma.
- Experienced
- AgranulocytosisDr. Schuetze isExperienced. Learn about Agranulocytosis.
- Breast CancerDr. Schuetze isExperienced. Learn about Breast Cancer.
- Chronic Familial NeutropeniaDr. Schuetze isExperienced. Learn about Chronic Familial Neutropenia.
- Endometrial CancerDr. Schuetze isExperienced. Learn about Endometrial Cancer.
- Epithelial-Myoepithelial CarcinomaDr. Schuetze isExperienced. Learn about Epithelial-Myoepithelial Carcinoma.
- Familial Adenomatous PolyposisDr. Schuetze isExperienced. Learn about Familial Adenomatous Polyposis.
- Heart TumorDr. Schuetze isExperienced. Learn about Heart Tumor.
- Inflammatory Breast CancerDr. Schuetze isExperienced. Learn about Inflammatory Breast Cancer.
- Legius SyndromeDr. Schuetze isExperienced. Learn about Legius Syndrome.
- Liver CancerDr. Schuetze isExperienced. Learn about Liver Cancer.
- Lung NodulesDr. Schuetze isExperienced. Learn about Lung Nodules.
- MelanomaDr. Schuetze isExperienced. Learn about Melanoma.
- NeurofibromatosisDr. Schuetze isExperienced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Dr. Schuetze isExperienced. Learn about Neurofibromatosis Type 1 (NF1).
- Opioid Induced ConstipationDr. Schuetze isExperienced. Learn about Opioid Induced Constipation.
- Paget Disease of the BreastDr. Schuetze isExperienced. Learn about Paget Disease of the Breast.
- Phantom Limb PainDr. Schuetze isExperienced. Learn about Phantom Limb Pain.
- Polymorphous Low Grade AdenocarcinomaDr. Schuetze isExperienced. Learn about Polymorphous Low Grade Adenocarcinoma.
- Pseudomyxoma PeritoneiDr. Schuetze isExperienced. Learn about Pseudomyxoma Peritonei.
- RASopathiesDr. Schuetze isExperienced. Learn about RASopathies.
- Severe Congenital NeutropeniaDr. Schuetze isExperienced. Learn about Severe Congenital Neutropenia.
- Solitary Fibrous TumorDr. Schuetze isExperienced. Learn about Solitary Fibrous Tumor.
- Stomach CancerDr. Schuetze isExperienced. Learn about Stomach Cancer.
- ThrombocytopeniaDr. Schuetze isExperienced. Learn about Thrombocytopenia.
- Vaginal CancerDr. Schuetze isExperienced. Learn about Vaginal Cancer.


